Filed Pursuant to Rule 424(b)(2)
Registration No. 333-270042
The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has become effective under the Securities Act of 1933. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where such offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED MARCH 8, 2023PRELIMINARY PROSPECTUS SUPPLEMENT
(To Prospectus dated February 27, 2023)
Shares
% Fixed-Rate Reset Series D Cumulative
Perpetual Redeemable Preferred Shares
(Liquidation Preference $25.00 Per Share)
We are offering of our % Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares, par value $0.01 per share (the “Series D Preferred Shares” or the “shares”).
Distributions on the shares are cumulative from and including the date of original issue and will be payable quarterly in arrears on March 15, June 15, September 15 and December 15 of each year, commencing on June 15, 2023, in each case when, as, and if declared by our board of directors out of funds legally available for such purpose. An initial distribution on the shares will be payable on June 15, 2023 in an amount equal to approximately $ per share. Distributions based on the stated liquidation preference of $25.00 per share will be payable on the shares at a rate equal to (i) from and including the date of original issue to, but excluding, June 15, 2028, % per annum, and (ii) thereafter, during each reset period, at a rate per annum equal to the five-year treasury rate as of the most recent reset distribution determination date (as described elsewhere in this prospectus supplement) plus a spread of basis points per annum.
At any time or from time to time on or after June 15, 2028, we may, at our option, redeem the shares, in whole or in part, at a redemption price of $25.00 per share, plus an amount equal to all accumulated and unpaid distributions thereon, if any, to, but excluding, the date of redemption, whether or not declared. In addition, prior to June 15, 2028, we may, at our option, redeem the shares, in whole but not in part, upon the occurrence of a Rating Event, a Series D Preferred Share Tax Redemption Event, or a Change of Control (each as defined herein) at the applicable redemption price set forth in “Description of the Series D Preferred Shares—Redemption.” If (i) a Change of Control occurs (whether before, on or after June 15, 2028) and (ii) we do not give notice prior to the 31st day following the Change of Control to redeem all of the outstanding shares, the distribution rate per annum on the shares will increase by 5.00%, beginning on the 31st day following such Change of Control. See “Description of the Series D Preferred Shares—Redemption.”
The shares will rank equally with each other series of our Parity Securities (as hereinafter defined) (including our Series A Preferred Shares, our Series B Preferred Shares and our Series C Preferred Shares), junior to our Senior Securities (as hereinafter defined) and senior to our Junior Securities (as hereinafter defined) with respect to payment of distributions and rights (including redemption rights) upon our liquidation, dissolution or winding up. See “Description of the Series D Preferred Shares—Ranking” and “Description of the Series D Preferred Shares—Priority Regarding Distributions.” The shares will not have any voting rights, except as set forth under “Description of the Series D Preferred Shares—Voting Rights.”
We intend to apply to list the shares on the Nasdaq Global Select Market (the “NASDAQ”) under the symbol “FTAIM.” If the application is approved, we expect trading of the shares on the NASDAQ to begin within 30 days after the shares are first issued. Currently, there is no public market for the shares.
Investing in the shares involves a high degree of risk. Before making a decision to invest in the shares, you should read the discussion of material risks of investing in the shares in “Risk Factors” beginning on page S-
12 of this prospectus supplement and the “Risk Factors” section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as updated by annual, quarterly and other reports we file with the Securities and Exchange Commission that are incorporated by reference in this prospectus supplement and the accompanying prospectus.
Neither the Securities and Exchange Commission nor any state or other securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
Public Offering Price | | | $ | | | $ |
Underwriting Discount(2) | | | $ | | | $ |
Proceeds Before Expenses to Us | | | $ | | | $ |
(1)
| Assumes no exercise of the underwriters’ option to purchase additional shares, as described below. |
(2)
| The underwriting discount will be $ per share. We refer you to “Underwriting” beginning on page S- 37 of this prospectus supplement for additional information regarding underwriting compensation. |
We have also granted the underwriters an option to purchase up to an additional shares at the public offering price, less the underwriting discount, within 30 days after the date of this prospectus supplement solely to cover overallotments, if any.
The underwriters are offering the shares as set forth under “Underwriting”. Delivery of the shares will be made on or about , 2023.
Joint Book-Running Managers
Morgan Stanley | | | Citigroup | | | J.P. Morgan |
RBC Capital Markets | | | Stifel | | | UBS Investment Bank |
Co-Managers
Benchmark Company | | | BTIG | | | Cantor | | | Compass Point | | | Jefferies |
JMP Securities | | | Oak Ridge Financial | | | Piper Sandler | | | Raymond James |
The date of this prospectus supplement is , 2023.